BlackRock
APMD

BlackRock’s Apnimed Inc APMD Stock Holding History

BlackRock’s Portfolio APMD Stock Details APMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18.7M Buy
+854,817
New +$23M ﹤0.01% 3276

Other funds holding APMD

Alpha Wave Global
Alpha Wave Global New York $4.27B AUM 12.79% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $1.08B AUM 14.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Sectoral Asset Management
Sectoral Asset Management Montreal, Quebec, Canada $157M AUM 41.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

BlackRock's APMD Position: Q3 2026 in Review

BlackRock opened a new position in Apnimed Inc (APMD) in Q3 2026: 854,817 shares worth $18.7M. The stake represents ﹤0.01% of the portfolio and ranks #3276 among its holdings.

42 funds tracked by Wall St. Rank hold APMD as of Q3 2026.

  • BlackRock held 854,817 shares of Apnimed Inc worth $18.7M as of Q3 2026.
  • Apnimed Inc was a new BlackRock position in Q3 2026.
  • Apnimed Inc made up ﹤0.01% of BlackRock's portfolio in Q3 2026, its #3276 holding.
  • 42 funds tracked by Wall St. Rank held Apnimed Inc as of Q3 2026.

Based on BlackRock's 13F filing for Q3 2026, filed 13 Nov 2026.